C the Signs is an AI-driven cancer prediction platform and MHRA Class I medical device, used in primary care to identify and refer patients at risk of cancer at the earliest and most treatable stage of the disease. Deployed across the NHS since 2017, it analyses clinical records and patient-reported data to accurately triage individuals, improving cancer detection rates and survival outcomes. With over 65,000 cancers detected across 100+ cancer types, C the Signs is redefining what’s possible in early diagnosis - giving patients back time, choice, and life itself.